Skip to Main Content

Paper Details

Mendelian randomization analyses of 23 known and suspected risk factors and biomarkers for breast cancer overall and by molecular subtypes.
Int J Cancer
18
2022
Author NameAffiliation
Wanqing WenVanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
Jirong LongVanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
Xiao-Ou ShuVanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
Wei ZhengVanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
  • 1 - 4

Datasets

Release 1.2